Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.

Angiogenesis in cancer, vascular, rheumatoid and other disease

Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627

Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization

Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,263

Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176

Bisphosphonates: Mechanisms of Action

Fleisch, H. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,109

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D., Mundy, G. R., & Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,039

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A. R., Mackey, J. R., Apffelstaedt, J., Hussein, M., Coleman, R. E., Reitsma, D. J., et al. (2001) · PubMed · Cited by 896

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

Wood, J. M., Bold, G., Buchdunger, E., Cozens, R. M., Ferrari, S. M., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., et al. (2000) · PubMed · Cited by 844

Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

Diel, I., Solomayer, E., Costa, S. D., Gollan, C., Goerner, R., Wallwiener, D. R., Kaufmann, M., & Bastert, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390601 · Cited by 809

In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices.

Montesano, R., Orci, L., & VASSALLI, P. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.97.5.1648 · Cited by 647

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

Berenson, J. R., Lichtenstein, A. K., Porter, L., Dimopoulos, M. A., Bordoni, R. E., George, S., Lipton, A., Keller, A. M., Ballester, O., Kovacs, M. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 645

Blindness resulting from bisphosphonate-related osteonecrosis of the skull base

Faraji, F., Antisdel, J. L., & Brunworth, J. D. (2016) · Acta Oto-Laryngologica Case Reports · doi:10.1080/23772484.2016.1209641 · Cited by 1

Impaired Osteoclastogenesis in Medication-Related Osteonecrosis and Potential Clinical Management with BMP-2

Xu, C., Xiao, Y., Wu, Y., Bakker, A. D., & Liu, Y. (2024) · Regenerative medicine and dentistry. · doi:10.53941/rmd.2024.100005 · Cited by 1

Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study

Husum, Y. S., Moe, M. C., Fagerland, M. W., Eriksen, E. F., & Jørstad, Ø. K. (2024) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2024-001964 · Cited by 1

Synergistic effects of sequential treatment with doxorubicin and zoledronic acid on anticancer effects in estrogen receptor-negative breast cancer cells

Danpipat, A., Rujimongkon, K., Adchariyasakulchai, P., Wilawan, N., & Ketchart, W. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03737-w · Cited by 1

Current approaches to bone-targeted therapy in genitourinary malignancies

Mulders, P. (2012) · Therapeutic Advances in Urology · doi:10.1177/1756287212453079 · Cited by 1

Zoledronic Acid Inhibits Angiogenesis Through Promoting HIF-1α Protein Degradation in Human Umbilical Vein Endothelial Cells

Ge, C., Sun, H., Li, Q., Lu, R., Zou, X., Yu, K., Li, X., Shu, Y., & Zhao, Y. (2016) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2016.1488 · Cited by 1

Bisphosphonates Treatment in Metastatic Prostate Cancer

Berardinelli, F., Iannucci, M., Verratti, V., Fusco, W., Nicolai, M., & Tenaglia, R. L. (2005) · European Journal of Inflammation · doi:10.1177/1721727x0500300201 · Cited by 1

Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

Radwan, I. A., Korany, N. S., & Ezzat, B. A. (2018) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2018.75030 · Cited by 1

Selection of Angiogenic Markers that Predict the Transition from Bisphosphonate Exposure to MRONJ in a Rat Model

(2018) · International Journal of Dental Research and Reviews · doi:10.28933/ijdrr-2018-10-1801 · Cited by 1

Preventive and therapeutic effects of relaxin on bisphosphonaterelated osteonecrosis of the jaw: an experimental study in rats

Develi, T., Uçkan, S., Bayram, B., Deniz, K., Erdem, R., Ozdemir, H. B., Tütüncü, N. B., & Bacanlı, D. (2020) · Brazilian Dental Science · doi:10.14295/bds.2020.v23i1.1846 · Cited by 1

Inhibitors of tumor angiogenesis

Harris, A. L., & Generali, D. (2008) · Elsevier eBooks · doi:10.1016/b978-012369448-5.50018-5 · Cited by 1

Histopathological alterations of the intrinsic tongue muscles following zoledronic acid treatment in a rat model

Farag, D. B. E., & Mehanny, S. (2020) · Dental and Medical Problems · doi:10.17219/dmp/115368 · Cited by 1

Medication Related Osteonecrosis of the Jaws: Definition, Prevention, Treatment and Current Approaches

SİVRİ, D., ATAK, S. Ç., Çeti̇ner, S., Öztürk, K., & Okur, B. (2020) · Turkiye Klinikleri Journal of Dental Sciences · doi:10.5336/dentalsci.2019-72332 · Cited by 1

Cellular and molecular actions of bisphosphonates

Munoz, M. A., & Rogers, M. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00025-6 · Cited by 1

Localised melorheostosis

Agarwal, S., Khanna, V., Varghese, M., & Suresh, B. (2017) · International Journal of Research in Orthopaedics · doi:10.18203/issn.2455-4510.intjresorthop20171915 · Cited by 1

Intraoperative Complications

Resnik, R. R., & Cillo, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37580-1.00008-1 · Cited by 1

Az osteoporosis antirezorptív kezelésének biológiai alapjai és az állcsontok antirezorptív kezelés okozta osteonecrosisa

Gera, I., & Szücs, N. (2024) · Fogorvosi Szemle · doi:10.33891/fsz.117.1.11-21 · Cited by 1

Assessing the intake of phytoestrogens: isoflavones

Lorenzetti, S., & Branca, F. (2003) · Elsevier eBooks · doi:10.1533/9781855736986.2.189 · Cited by 1

Six months of resistance training or plyometrics exercise positively affects bone mineral density and bone turnover marker ratios in men with osteopenia

Dawson, A. W. (2011) · MOspace Institutional Repository (University of Missouri) · Cited by 1

Estudo da presença de osteonecrose na madíbula após exodontia de molares em ratos tratados com alendronato de sódio

Yamamoto‐Silva, F. P. (2010) · doi:10.11606/t.23.2010.tde-09112010-111814 · Cited by 1

Les bisphosphonates dans le cancer de la prostate

Paule, B. (2004) · ONCOLOGIE · doi:10.1007/s10269-004-0109-5 · Cited by 1

Chapter 107. Bisphosphonate‐Associated Osteonecrosis of the Jaws

Treister, N. S., & Woo, S. (2008) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9780470623992.ch107 · Cited by 1

Vascular Disease and the Skeleton

Towler, D. A. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch121 · Cited by 1

Guidelines for the use of bisphosphonates in bone metastases

Coleman, R. E. (2003) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(03)90034-6 · Cited by 1

The Truth About Osteonecrosis of the Jaw

Khan, M., & Khan, A. A. (2006) · Cited by 1

New insights into the mechanisms of bisphosphonates action

Tsetsenekou, E., & Kalyvas, D. (2010) · Cited by 1

Osteonecrose dos maxilares associada a bisfosfonatos

Pereira, F. D. A., Pereira, J. C., Alisson, C., Pereira, A., de Carvalho, R. W. F., de Carvalho, F., & Antunes, A. A. (2009) · Rev. bras. cir. cabeça pescoço · Cited by 1

A case of bisphosphonate-induced osteonecrosis of the mandible

Ozawa, T., Matsui, Y., Watanuki, K., FURUSE, S., Mogi, T., & Tohnai, I. (2008) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.54.261 · Cited by 1

Biphosphonates In The Management Of Metastatic Bone Disease

Fred Saad, C., & Hussain, A. (2009) · Cancer metastasis · doi:10.1007/978-1-4020-9819-2_10 · Cited by 1

Skeletal Complications of Malignancy: Central Role for the Osteoclast

Clines, G. A., Chirgwin, J. M., & Guise, T. A. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_9 · Cited by 1

Bisphosphonate‐Associated Osteonecrosis of the Jaws

Mawardi, H. H., Treister, N. S., & Woo, S. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch112 · Cited by 1

Heterotopic ossification secondary to injury: insights from a novel zebrafish model

Kaliya-Perumal, A.-K. (2024) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/179501 · Cited by 1

Critical insights on bisphosphonates with high bone-resorption-capacity promote osteonecrosis of the jaw development after tooth extraction in mice

Karim, I., Ahmad, U., Khan, M. S., & Ullah, M. (2025) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-025-01622-x · Cited by 1

Bisphosphonates in the Treatment of Myeloma Bone Disease

Berenson, J. R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-554-5_6

Etiopathogenesis and Clinical Aspects of BIONJ

Ferrara, S., Vuolo, L., Colao, A. A. L., & Califano, L. (2011) · Springer eBooks · doi:10.1007/978-88-470-2083-2_7

Comparison of cytotoxic properties of free and liposomal bisphosphonates in vitro

Frei, R. (2005) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005075555

Novel Osteoarthritis Therapeutics

Bingham, C. O. (2007) · Springer eBooks · doi:10.1007/978-1-84628-701-5_11

Role of Bisphosphonates in Skeletal Metastases

Hussain, A., & Fred Saad, C. (2005) · Humana Press eBooks · doi:10.1385/1-59259-892-7:305

Bisphosphonate bei malignen Knochentumoren

Holzer, G. (2009) · Der Orthopäde · doi:10.1007/s00132-008-1375-5

Estudo retrospectivo de osteonecrose dos maxilares associado ao uso dos bisfosfonatos em pacientes oncológicos: fatores de risco, aspectos clínicos, imagenológicos e terapêuticos

Martins, M. A. T. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.23.2009.tde-29092009-075642

Effect of bisphosphonates and small cyclic peptides on matrix metalloproteinases and human cancer cells

Heikkilä, P. (2005) · Työväentutkimus Vuosikirja

Zoledronic Acid: Its Use in the Treatment of Breast Cancer

Vaz-Luís, I., Casimiro, S., Ribeiro, J. M., & Costa, L. (2010) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s2353

Ρόλος των προ - και αντι - αποπτωτικών γονιδίων στην παθογένεια του πολλαπλού μυελώματος

Xagoraris, I. (2005) · doi:10.12681/eadd/26496

Zoledronic acid inhibit angiogenesis and impairs tumorigenesis in a mouse model of cervical carcinogenesis

Giraudo, E., & Hanahan, D. (2009) · Institutional Research Information System University of Turin (University of Turin) · doi:10.4081/hmr.v2i3.371

C6 Immunostimulants in cancer therapy

Talmadge, J. E. (2011) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0346-0136-8_21

Antiangiogenic activity of zoledronic acid: inhibition of the VEGF-VEGFR-2 autocrine loop in the endothelial cells of patients with multiple myeloma

Vacca, A., Scavelli, C., Pietro, G. D., Cirulli, T., & Ribatti, D. (2009) · CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) · doi:10.4081/hmr.v2i3.376

Angiogenesis in Breast Cancer: Molecular Markers, Therapeutic Targets, Antiangiogenic Therapy & Inhibitors

Lima, C. S. P., Lourenço, G. J., & Rinck, J. A. (2010) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805007911001010068

Progress Toward Understanding the Etiology of Otosclerosis and Implications for Future Management

McKenna, M. J. (2009) · Otology Japan · doi:10.11289/otoljpn.19.113

Santé buccodentaire et patients sous bisphosphonates

Radoï, L., & Folliguet, M. (2010) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2010.10.004

Zoledronic Acid Disrupts VEGFR2 Intracellular Trafficking in Endothelial Cells

Basi, D. L. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.05.153

Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion

Pigozzo, J., Rossi, C. D., Rossi, C. R., Nitti, D., & Chiarion‐Sileni, V. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e3283252fda

Hipercalcemia del adulto

Vieillard, M.-H., Gerot-Legroux, I., & Cortet, B. (2009) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(09)70888-3

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

Cisterna, C., Nicolás Yanine, M., González, C., & Julio Villanueva, M. (2008) · Revista clínica de periodoncia implantología y rehabilitación oral · doi:10.1016/s0718-5391(08)70007-7

De invloed van medicatie en chirurgische ingrepen op de doorbloeding van orale weefsels

Milstein, D. M. J., & Lindeboom, J. A. H. (2013) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0455-4_16

The effect of alendronates administration duration on the healing of extraction socket in rats: pilot study

Kim, J., Hong, J.-H., Choi, H., Park, Y., & Moon, H. (2013) · The Journal of Korean Academy of Prosthodontics · doi:10.4047/jkap.2013.51.3.175

Étude intra vitale de la vascularisation en site osseux membraneux et effet de l'acide zolédronique : mise au point d'un modèle chez le rat

Paccou, J., Vieillard, M.-H., Penel, G., & Cortet, B. (2007) · Revue du Rhumatisme · doi:10.1016/j.rhum.2007.10.559

Estudo dos efeitos dos bifosfonatos na angiogénese/osteogénese do tecido ósseo: avaliação in vitro em co-culturas de osteoblastos e células endoteliais

Ribeiro, V. P. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Bisphosphonates: from preclinical evidence to survival data in the oncologic setting

Santini, D., Galluzzo, S., Fratto, M. E., Vincenzi, B., Angeletti, S., Dicuonzo, G., Schiavon, G., & Tonini, G. (2007) · Oncology Reviews · doi:10.1007/s12156-007-0017-1

Bisphosphonates and metastasis

Lester, J., & Coleman, R. E. (2005) · Breast Cancer Online · doi:10.1017/s1470903104002676

Análise molecular e microscópica do reparo ósseo de alvéolos dentários após exodontia em um modelo de osteonecrose dos maxilares induzida pelo ácido zoledrônico em ratos Wistar

Filho, E. V. Z. (2014) · doi:10.11606/d.25.2014.tde-08092014-103848

Clinical aspects of bisphosphonate-associated oralosteonecrosis in patients with multiple myeloma

Gaglioti, D., Andriani, A., Colasanti, U., Papa, R., Villivà, N., & Riva, C. (2006) · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche)

Randomized double-blind clinical comparison of sodium ibandronate and pamidronate disodium for treatment of 141 patients with malignant tumor ostealgia

Dai, G., Jiao, S., Yang, J., Jiang, S., & Liu, D. (2007) · Chinese Journal of Clinical Oncology · doi:10.1007/s11805-007-0103-y

Osteonecrosis of the Maxilla in a Patient with a History of Bisphosphonate Therapy (L'ostéonécrose du maxillaire chez un patient ayant déjà été traité avec les biphosphonates)

Melo, M. D. (2005)

Bisphosphonate-induced Jaw Osteonecrosis (BJON) & Its Management Strategy

Dayma, V. K., & Demonstrator (2011)

Osteonecrosis of the jaws associated with the use of zoledronic acid in multiple myeloma patients

Kraj, M. A., Pogłód, R., Maj, S., Mendek‐Czajkowska, E., & Owczarska, K. (2006) · Via Medica Journals

Bisphosphonates and osteomyelitis of the jaw

Bereznicki, L., & Peterson, G. M. (2008) · eCite Digital Repository (University of Tasmania)

Hydronium (3-oxo-1-phosphono-1,3-dihydroisobenzofuran-1-yl)phosphonate

Barbey, C., Retailleau, P., Guénin, E., & Dupont, N. (2009) · Acta Crystallographica Section E Structure Reports Online · doi:10.1107/s1600536809000907

Efeito da oxigenoterapia hiperbárica sobre o reparo alveolar pós-exodontia em ratos Wistar tratados com bisfosfonato: análise histomorfométrica e imunoistoquímica

Silva, M. L. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

BRONJ: The Future

Ruggiero, S. L. (2011) · Springer eBooks · doi:10.1007/978-88-470-2083-2_15

Palliative Bestrahlung mit 60Co-Teletherapie beim appendikularen Osteosarkom des Hundes

Kandel-Tschiederer, B. (2009) · Qucosa (Saxon State and University Library Dresden)

Dissecting the molecular mechanisms of breast cancer bone metastasis for therapeutic targeting

Pollari, S. (2012) · UTUPub (University of Turku)

A CASE OF DELAYED ONSET OF OSTEONECROSIS OF THE JAW IN ASSOCIATION WITH BISPHOSPHONATE TREATMENT FOR BONE METASTASES FROM BREAST CANCER

Onoue, S., Takao, K. U. N. O., Yoshida, K., Koide, N., Torimoto, Y., & Iida, K.-I. (2009) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.70.1319

Ostéonécroses de la mâchoire et bisphosphonates

Naveau, A., & Naveau, B. (2005) · Revue du Rhumatisme · doi:10.1016/j.rhum.2005.10.012

Mandibular fracture in a patient treated with long-term antiangiogenic therapy and previous bisphosphonate exposure

Davis, T., Summerlin, D., Moore, M. G., Younger, A., & Chiorean, E. G. (2011) · Community Oncology · doi:10.1016/s1548-5315(12)70090-6

Cure of a case of osteonecrosis of the mandible associated with an oral bisphosphonate

Yamashita, T., MATSUMOTO, Y., Asaka, Y., Makita, H., Toida, M., & Shibata, T. (2008) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.54.243

Bone Marrow Mast Cell Density Correlates with Circulating Biomarkers of Bone Disease in Multiple Myeloma

Vyzoukaki, R., Devetzoglou, M., Pappa, C. A., Antonakis, A., Masud, S., Papadopoulou, A., Tsirakis, G., & Alexandrakis, M. G. (2016) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2016/25402

Risikofaktoren und klinische Präsentation

Schreyer, C. (2012)

Acido zoledronico e patologie ossee in corso di neoplasia: Parte II

Caffo, O. (2005) · Tumori Journal · doi:10.1177/030089160509100630

Estudio experimental para la valoración de la cicatrización ósea con Ácido Zoledrónico en ratas Wistar

Palomero, C. M., López, P. G., Sanz, P., Hernández, A. I., Carrizosa, C. L., & Sánchez, D. G. (2015) · Sanidad militar: revista de sanidad de las Fuerzas Armadas de España · doi:10.4321/s1887-85712015000400003

Risk-Reducing (Chemopreventive) Agents in Breast Cancer Prevention

Gronich, N., & Rennert, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-27135-4_8

OSTEONECROSE DA MANDÍBULA E/OU MAXILAS EM PACIENTES SUBMETIDOS À TERAPIA COM BISFOSFONATOS

Pinto, V. M. C. (2010)

Development of Novel Nanomedicines for Treatment of Primary and Metastatic Prostate Cancer.

Aydin, Ö. F. (2016) · Deep Blue (University of Michigan)

Dental CT: Pathologic Findings in the Teeth and Jaws

Wuest, W. (2017) · Medical radiology · doi:10.1007/174_2017_21

Polimorfismos de los genes reguladores de la angiogénesis en la Enfermedad Ósea de Paget

Paniagua, I. C. (2015) · doi:10.14201/gredos.128823

Osteonecrosis of the Jaw

Badros, A. Z. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-554-5_7

Contributions of the Bone Marrow Microenvironment to Bone and Skeletal Metastasis.

Soki, F. N. (2014) · Deep Blue (University of Michigan)

Biomaterials, Dental Implants, and Compromised Osseous tissue

Babu, A., & Ogle, O. E. (2015)

Bilateral Atypical Femoral Shaft Fractures and Bisphosphonate Therapy; A Case Report

Glynn, A. A. (2017) · MOJ Orthopedics & Rheumatology · doi:10.15406/mojor.2017.08.00314

Prevention of Bone Necrosis in Patients with Cancer

Hupp, W. S., & Migliorati, C. A. (2006) · Supportive Cancer Therapy · doi:10.3816/sct.2006.n.017

Odontogenic bacterial infections

Dashper, S., Nastri, A., & Abbott, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-28100-1_45-1 · Cited by 5

BISPHOSPHONATE INDUCED OSTEONECROSIS OF THE JAWS AND CURRENT THERAPIES

Torul, D., & Bereket, M. C. (2017) · Cumhuriyet Dental Journal · doi:10.7126/cumudj.345953

Effect of Bisphosphonates on Osteoblast Differentiation and Mineralization of Human Dental Pulp Stem Cell

Oh, J.-S., Ryu, M. H., Kim, H. J., Shin, S., & Lee, J. Y. (2017) · 대한구강악안면병리학회지 · doi:10.17779/kaomp.2017.41.5.002

Osteonecrosis of the jaws in a patient with multiple myeloma - a case report

Mendes, V. L. D. D. C., Paoli, F. D., & Hespanhol, W. (2018) · Revista Brasileira de Odontologia · doi:10.18363/rbo.v75.2018.e1184

Use of Bisphosphonates in Hematology

Musolino, C., & Allegra, A. (2011) · Springer eBooks · doi:10.1007/978-88-470-2083-2_4

ARTICLE IN PRESS G Model

Smethurst, P. J., Almeida, A. C., & Loos, R. A. (2014)

BİFOSFONAT KULLANIMINA BAĞLI ÇENE KEMİKLERİNDE GÖRÜLEN OSTEONEKROZ VAKALARININ MEDİKAL VE CERRAHİ TEDAVİLERİ SONRASI UZUN DÖNEM TAKİPLERİ

Erdem, N. F., & Gümüşer, Z. (2018) · Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi · doi:10.17567/ataunidfd.443391

Pharmaceutical management of bone catabolism: the bisphosphonates

Raubenheimer, E., Noffke, C., Lemmer, L., Slavík, T., Heerden, W. V., & Miniggio, H. D. (2019) · The South African Orthopaedic Journal (SAOJ) · doi:10.17159/2309-8309/2019/v18n1a6

Targeted Therapies for Bone Metastases

Santini, D., Spoto, C., Longo, V., Iuliani, M., Zoccoli, A., Intagliata, S., Pantano, F., & Silvestris, F. (2015) · Current clinical pathology · doi:10.1007/978-1-4939-2047-1_18

Altered VEGF Regulation in Ovariectomized Rat Alveolar Bone Sockets by Bisphosphonate

Yang, D., Kim, S.-H., & Han, G.-D. (2018) · The Korean Journal of Oral Anatomy · doi:10.35607/kjoa.39.1.201812.005

Osteonecrose dos maxilares associada a bisfosfonatos: avaliação genética em pacientes oncológicos

Caldas, R. J. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.25.2019.tde-27082019-203349

Bisphosphonates: new antiangiogenic molecules in cancer treatment?

Vincenzi, B., Santini, D., Rocci, L., & Tonini, G. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg194 · Cited by 29

The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.

Bäckman, U., Svensson, Å., Christofferson, R. H. B., & Azarbayjani, F. (2008) · PubMed · Cited by 30

Zoledronic Acid Suppresses Vasculogenesis: A New Effect of Bisphosphonates.

Chen, H., Wang, C. S., Li, J. S. Y., Campbell, R. A., Li, M., Sanchez, E., Steinberg, J. A., Share, M., Shalitin, D., Wang, J., et al. (2007) · Blood · doi:10.1182/blood.v110.11.3913.3913

Investigation of the Antiangiogenic Properties of Zoledronic Acid by Using Chorioallantoic Membrane Model

Gülcü, A., & Akkaya, Ö. (2022) · Dose-Response · doi:10.1177/15593258221093410 · Cited by 3

No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site

Biver, E., Vieillard, M.-H., Cortet, B., Salleron, J., Falgayrac, G., & Penel, G. (2009) · Bone · doi:10.1016/j.bone.2009.10.034 · Cited by 15